September 19, 2017
Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone repair and generation, and it’s the first in the U.S. to incorporate magnesium, a critical property for bone health and development.
“We’re excited to bring this important orthopedic technological advancement to the market,” says BSI president and CEO, Drew Diaz. “OsteoCrete® provides surgeons a much-needed option currently not available, as it’s the only bone-repair product made with magnesium.”
“Many modern devices used for bone repair or replacement are calcium-based and do not exhibit a combination of compressive strength and expandability necessary for optimal binding quality,” Diaz stated. OsteoCrete® is also resorbable, or capable of being assimilated back into the body, as it is replaced with bone as the patient heals. OsteoCrete® is also injectable, moldable, and biocompatible.
Magnesium contains high specific strength and an elastic modulus that closely resembles human bone. Most of the magnesium in the body (60%) is stored in bone and helps to preserve and develop bone structure by working with Vitamin D and calcium. Its effectiveness was a key component of BSI’s approach to developing its OsteoCrete® technology.
The FDA has cleared this orthopedic platform technology for use in bone-related surgical procedures ranging from complex sport-related injuries to all musculoskeletal extremities trauma cases.
“We’ve been fortunate to have surgeons test OsteoCrete® in various studies, and they were impressed about its positive effects and performance. It’s an incredible development for both patients and surgeons,” Diaz stated.
OsteoCrete® is currently being distributed to clinics and surgical centers around the country for immediate use.
About Bone Solutions Inc.
Bone Solutions Inc. (‘BSI’) (http://www.bonesolutionsinc.com) is an orthobiologics company with a vision to provide orthopedic surgeons a means to improve clinical outcomes in a number of complex procedures while lowering costs. The company is revolutionizing a new solution for orthopedic surgeons for human uses with their FDA-cleared magnesium-based platform bone void filler.